hsa-miR-199a

ncRNA information

ncRNA name

hsa-miR-199a

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

YES1

Cancer information

Cancer name

Prostate Cancer

Cancer site

Prostate

Treatment information

Treatment type

Chemotherapy

Drug

Paclitaxel

Impact of wild-type ncRNA on chemotherapy resistance

Down

Impact of knockdown of ncRNA on chemotherapy resistance

Up

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Down

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

He downregulation of miR-199a contributes to PTX resistance in prostate cancer.

Tissue resource

normal prostate and prostate cancer specimens

prostate cancer cell lines PC3

Experiment

qRT-PCR,Western blot,Dual-luciferase reporter assay


Institute

Shanghai University of Traditional Chinese Medicine Affiliated LONGHUA Hospital

American Type Culture Collection

Country

China

USA

Continent

Asia

North American